Atlas Trials

Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

Clinical trial NCT00628433 · COMPLETED

Trial details

NCT number
NCT00628433
Sponsor
Harbor Therapeutics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2008-02-01
Primary completion
2009-05-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.